140 related articles for article (PubMed ID: 6909271)
1. Simple methods for preparing EAC1,4b,2a,3b and EAC4b,3b with human or guinea pig complement components using an anticomplementary agent, K-76 monocarboxylic acid.
Hong K; Kinoshita T; Inoue K
J Immunol; 1981 Jul; 127(1):109-14. PubMed ID: 6909271
[No Abstract] [Full Text] [Related]
2. An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade.
Hong K; Kinoshita T; Miyazaki W; Izawa T; Inoue K
J Immunol; 1979 Jun; 122(6):2418-23. PubMed ID: 448130
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of K-76 monocarboxylic acid, an anticomplementary agent, on the C3b inactivator system.
Hong K; Kinoshita T; Kitajima H; Inoue K
J Immunol; 1981 Jul; 127(1):104-8. PubMed ID: 7240739
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric assay for phagocytosis of human monocytes mediated via Fc gamma-receptors and complement receptor CR1 (CD35).
Andoh A; Fujiyama Y; Kitoh K; Hodohara K; Bamba T; Hosoda S
Cytometry; 1991; 12(7):677-86. PubMed ID: 1838328
[TBL] [Abstract][Full Text] [Related]
5. Dual function of insoluble polyanions. Formation of C1 and C42 sites in addition to activation of the alternative pathway of complement.
Burger R; Loos M; Kossorotow A; Hadding U; Bitter-Suermann D
Monogr Allergy; 1977; 12():78-81. PubMed ID: 917023
[No Abstract] [Full Text] [Related]
6. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
Hammer CH; Abramovitz AS; Mayer MM
J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of lyophilized reagents for determining the functional activity of complement C1, C2, C3, C4 and C5 components].
Nikiforova TV; Kuznetsova NN; Vavilova LM
Lab Delo; 1988; (3):28-31. PubMed ID: 2453712
[No Abstract] [Full Text] [Related]
8. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
Houle JJ; Hoffmann EM
J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
[TBL] [Abstract][Full Text] [Related]
9. Complement receptors on guinea pig epidermal Langerhans cells.
Berman B; Gigli I
J Immunol; 1980 Feb; 124(2):685-90. PubMed ID: 7356709
[TBL] [Abstract][Full Text] [Related]
10. Hemolytic efficiency of cell-bound IgM: evidence that IgM-C1 complexes activate C4 molecules not hemolytic with homologous C2--C9.
Ejzemberg R; Borsos T
J Immunol; 1982 Apr; 128(4):1600-2. PubMed ID: 7061844
[TBL] [Abstract][Full Text] [Related]
11. Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a.
Nicholson-Weller A; Burge J; Austen KF
J Immunol; 1981 Nov; 127(5):2035-9. PubMed ID: 6913607
[TBL] [Abstract][Full Text] [Related]
12. Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4).
Wilson AB; Prichard-Thomas S; Lachmann PJ; Coombs RR
Immunology; 1980 Feb; 39(2):195-202. PubMed ID: 7380467
[TBL] [Abstract][Full Text] [Related]
13. Developmental aspects of complement components in the newborn. The presence of complement components and C3 proactivator (properdin factor B) in human colostrum.
Ballow M; Fang F; Good RA; Day NK
Clin Exp Immunol; 1974 Oct; 18(2):257-66. PubMed ID: 4478765
[TBL] [Abstract][Full Text] [Related]
14. Alternative complement pathway activation by C4b deposited during classical pathway activation.
Matsushita M; Okada H
J Immunol; 1986 Apr; 136(8):2994-8. PubMed ID: 2937839
[TBL] [Abstract][Full Text] [Related]
15. Quantitative determination of complement components produced by purified hepatocytes.
Ramadori G; Rasokat H; Burger R; Meyer Zum Büschenfelde KH; Bitter-Suermann D
Clin Exp Immunol; 1984 Jan; 55(1):189-96. PubMed ID: 6692595
[TBL] [Abstract][Full Text] [Related]
16. The complement system in hemolytic-uremic syndrome in childhood.
Monnens L; Molenaar J; Lambert PH; Proesmans W; van Munster P
Clin Nephrol; 1980 Apr; 13(4):168-71. PubMed ID: 7379368
[TBL] [Abstract][Full Text] [Related]
17. Activation of the classical and alternate pathways of complement by Corynebacterium parvum.
McBride WH; Weir DM; Kay AB; Pearce D; Caldwell JR
Clin Exp Immunol; 1975 Jan; 19(1):143-7. PubMed ID: 1204238
[TBL] [Abstract][Full Text] [Related]
18. The activation of complement components by aggregates of antibodies and their fragments.
Dodds AW; Porter RR
Mol Immunol; 1979 Dec; 16(12):1059-62. PubMed ID: 542202
[No Abstract] [Full Text] [Related]
19. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
20. Mode of interaction of different polyanions with the first (C1,C1) the second (C2) and the fourth (C4) component of complement. IV. Activation of C1 in serum by polyanions.
Loos M; Bitter-Suermann D
Immunology; 1976 Dec; 31(6):931-4. PubMed ID: 186401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
